Results 121 to 130 of about 9,122 (283)

Micro-RNAS that control myosin expression and myofiber identity [PDF]

open access: yes, 2015
The present invention relates to the identification of two microRNAs, miR-499 and miR-208b, that repress fast skeletal muscle contractile protein genes. Expression of miR-499 and/or miR-208b can be used to repress fast fiber genes and activate slow fiber
Olson, Eric N., van Rooij, Eva
core   +1 more source

Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex [PDF]

open access: yes, 2018
Rationale: Pupillometry can be used to characterize autonomic drug effects. Objective: This study was conducted to determine the autonomic effects of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), administered alone and after pretreatment with ...
Hysek, Cédric, Liechti, Matthias
core  

The phantom limb [PDF]

open access: yes, 1951
Thesis (M.D.)—Boston ...
Freed, Murray
core  

Body Condition and the Adrenal Stress Response in Captive American Kestrel Juveniles [PDF]

open access: yes, 1998
We examined the adrenal response to handling stress of birds in different body conditions. In order to affect the birds’ body condition, young (73-d old) female American kestrels (Falco sparverius) were maintained for 6 wk on one of three diets: a ...
Dufty, Alfred M., Jr., Heath, Julie A.
core   +2 more sources

Comparison of the eficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphineinduced pruritus [PDF]

open access: yes, 2014
Objective: To compare the eficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphine-induced pruritus, in patients at the “Dr.
Cano García, Martha Araceli   +6 more
core  

Central sympatholytic drugs.

open access: yesJournal of clinical hypertension (Greenwich, Conn.), 2012
•  Central sympatholytic drugs reduce blood pressure mainly by stimulating central α(2) -adrenergic receptors in the brainstem centers, thereby reducing sympathetic nerve activity and neuronal release of norepinephrine to the heart and peripheral circulation.
Wanpen, Vongpatanasin   +3 more
openaire   +1 more source

Angiotensin receptor-1 antagonist eprosartan in patients with mild to moderate arterial hypertension

open access: yesКардиоваскулярная терапия и профилактика, 2005
Aim. To study clinical effectiveness of eprosartan mesylate in treating patients with Stage I-II arterial hypertension (AH). Material and methods. In total, 28 patients (20 males, 8 females) with Stage I-II AH, risk 2-3, aged 28-56 years (mean age 40.0±1.
A. V. Shabalin   +2 more
doaj  

Progress on the Mechanisms and Neuroprotective Benefits of Dexmedetomidine in Brain Diseases

open access: yesBrain and Behavior
Introduction Dexmedetomidine, a highly specific α2 agonist, has been extensively utilized in clinical sedation and surgical anesthesia since its introduction in 2000 due to its excellent sympatholytic, sedative, and analgesic effects.
Zhenxing Tao, Pengpeng Li, Xudong Zhao
doaj   +1 more source

Home - About - Disclaimer - Privacy